Lastest Insider Transactions Of Acrivon Therapeutics, Inc. ( ACRV )
SymbolCompany NameInsider NameTitleDateTransationSharePriceAmountFile Date
ACRVAcrivon Therapeutics, Inc.PERCEPTIVE ADVISORS LLC 10% Owner2025-04-30Sell736,7671.381,017,9192025-05-01 19:07:20
ACRVAcrivon Therapeutics, Inc.PERCEPTIVE ADVISORS LLC 10% Owner2025-04-25Sell1,519,9521.812,744,9462025-04-29 19:26:12
ACRVAcrivon Therapeutics, Inc.Devroe EricChief Operating Officer2024-05-17Option Exercise10,0001.0410,4002024-05-21 16:04:32
ACRVAcrivon Therapeutics, Inc.PERCEPTIVE ADVISORS LLC 10% Owner2024-04-11Buy2,353,0008.5020,000,5002024-04-15 08:53:49
ACRVAcrivon Therapeutics, Inc.Chione Ltd 10% Owner2023-06-26Sell1612.932072023-06-28 15:47:14
ACRVAcrivon Therapeutics, Inc.Holm-Jorgensen RasmusChief Financial Officer2023-06-16Option Exercise9,5003.6334,4852023-06-20 17:21:20
ACRVAcrivon Therapeutics, Inc.Chione Ltd 10% Owner2023-06-15Sell2,05612.1424,9602023-06-20 17:15:32
ACRVAcrivon Therapeutics, Inc.Chione Ltd 10% Owner2023-06-12Sell5,89312.2972,4122023-06-14 18:33:30
ACRVAcrivon Therapeutics, Inc.Devroe EricChief Operating Officer2023-06-05Option Exercise9,2251.049,5942023-06-06 16:15:49
ACRVAcrivon Therapeutics, Inc.Blume-Jensen PeterPresident and CEO2023-05-31Option Exercise33,6053.88130,3872023-06-01 20:40:34